|
Tue, 04/21/2020 - 06:19 |
European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) |
|
Tue, 04/21/2020 - 04:41 |
Boehringer Ingelheim puts patient needs first as reflected in the results of the latest PatientView survey |
|
Thu, 04/09/2020 - 05:54 |
Boehringer Ingelheim Biopharmaceuticals China receives Facility of the Year Award |
|
Wed, 04/08/2020 - 08:38 |
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic |
|
Wed, 04/08/2020 - 02:51 |
COVID-19: Boehringer Ingelheim steps up effort with Global Support Program |
|
Mon, 03/16/2020 - 12:32 |
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib |
|
Mon, 03/16/2020 - 10:37 |
The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards |
|
Fri, 02/28/2020 - 18:16 |
Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease |
|
Thu, 02/27/2020 - 00:32 |
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform |
|
Tue, 02/18/2020 - 16:11 |
Boehringer Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox |
|
Mon, 02/17/2020 - 04:24 |
Boehringer Ingelheim kicks off a project based on behavioral science to improve cattle well-being |
|
Tue, 02/04/2020 - 00:30 |
Boehringer Ingelheim receives approval for Aservo EquiHaler, industry first therapy for severe equine asthma |
|
Thu, 01/09/2020 - 15:52 |
Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases |
|
Fri, 01/03/2020 - 11:40 |
Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX |
|
Mon, 12/30/2019 - 06:40 |
Milestone for Biopharmaceuticals in China |
|
Mon, 12/09/2019 - 05:02 |
Boehringer Ingelheim announces BVDzero Case Awards 2020 |
|
Sun, 11/03/2019 - 23:59 |
The new African Swine Fever Manual published |
|
Tue, 10/29/2019 - 10:26 |
Boehringer Ingelheim joins forces with The Defeat-NCD Partnership to fight non-communicable diseases |
|
Tue, 10/29/2019 - 10:07 |
Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing |
|
Mon, 10/07/2019 - 08:49 |
Winners of the 2019 European PRRS Research Award announced |
|
Tue, 10/01/2019 - 03:09 |
Boehringer Ingelheim obtains EMA authorization for Reprocyc ParvoFLEX, a new porcine parvovirus vaccine |
|
Fri, 09/27/2019 - 09:24 |
New therapeutic indications for NexGard, NexGard SPECTRA and Broadline approved by EMA |
|
Thu, 09/26/2019 - 02:50 |
Boehringer Ingelheim donates vaccines to help fight rabies |
|
Fri, 09/20/2019 - 08:09 |
Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health |
|
Fri, 09/20/2019 - 06:56 |
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases |
|
Thu, 09/12/2019 - 01:00 |
Boehringer Ingelheim showcases its leading avian vaccines and services at WVPAC 2019 |
|
Wed, 09/04/2019 - 02:22 |
Boehringer Ingelheim Expands KRAS Cancer Program with Lupins Clinical Stage MEK Inhibitor Compound |
|
Tue, 09/03/2019 - 02:28 |
Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes |
|
Mon, 08/19/2019 - 04:54 |
Social entrepreneurs improve healthcare access across the African continent |
|
Mon, 08/12/2019 - 07:19 |
Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies |
|
Mon, 08/12/2019 - 03:50 |
Boehringer Ingelheim opens Health Management Centre in China |
|
Thu, 08/01/2019 - 07:32 |
First half 2019: High levels of investment in R&D and robust organic growth |
|
Mon, 07/15/2019 - 08:12 |
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform |
|
Mon, 07/08/2019 - 06:29 |
Speech recognition can detect warning signals for schizophrenia or Alzheimer's dementia |
|
Mon, 07/01/2019 - 08:12 |
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation |
|
Thu, 06/20/2019 - 10:48 |
Collaboration key to meeting consumers expectations for better animal welfare |
|
Mon, 06/17/2019 - 12:27 |
Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRP Antagonist Monoclonal Antibody, |
|
Mon, 06/17/2019 - 08:18 |
Boehringer Ingelheim announces winners of BVDzero Scholarship Programme |
|
Tue, 06/11/2019 - 08:41 |
Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance |
|
Tue, 06/11/2019 - 06:28 |
Boehringer Ingelheim relies on digital transformation |
|
Tue, 06/04/2019 - 18:48 |
Boehringer Ingelheim partners with Constantia Flexibles to provide augmented reality packaging experience |
|
Mon, 06/03/2019 - 18:28 |
Boehringer Ingelheim and PharmAccess launch digital healthcare program in Kenya |
|
Wed, 05/29/2019 - 02:20 |
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists |
|
Sun, 05/19/2019 - 23:36 |
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD1 |
|
Sun, 05/19/2019 - 21:47 |
About Animal Health Business Unit |
|
Sun, 05/19/2019 - 21:37 |
Veterinary oncology experts from Europe, Japan and the US meet in Germany |
|
Mon, 05/13/2019 - 19:32 |
Digital transformation: Boehringer Ingelheim fosters cooperation with innovative partners |
|
Fri, 05/10/2019 - 11:52 |
Boehringer Ingelheim and Harbin Veterinary Research Institute set up industry-academia-research exchange platform |
|
Wed, 05/01/2019 - 23:48 |
Boehringer Ingelheim announces finalists of the Making More Health Accelerator Program |
|
Wed, 04/17/2019 - 12:23 |
Annual Results Press Conference |
|
Wed, 04/17/2019 - 10:15 |
Financial year 2018: Boehringer Ingelheim grows and invests |
|
Mon, 04/15/2019 - 04:34 |
Boehringer Ingelheim acquires stake in SoundTalks NV, begins pilot programme |
|
Thu, 04/11/2019 - 04:52 |
Major investment for respiratory diseases completed |
|
Thu, 04/11/2019 - 02:29 |
Boehringer Ingelheim celebrates 20 years of Metacam for cattle |
|
Tue, 04/09/2019 - 05:13 |
Boehringer Ingelheim launches the first-ever registered stem cell-based veterinary medicine |
|
Wed, 04/03/2019 - 13:04 |
Why we may be more like our pets than we think |
|
Tue, 04/02/2019 - 12:12 |
Boehringer Ingelheim launches BVDzero scholarship for veterinary students globally |
|
Mon, 04/01/2019 - 15:54 |
Boehringer Ingelheim and Dopharma complete the acquisition of Saint-Herblon production site |
|
Fri, 03/29/2019 - 12:18 |
Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics |
|
Fri, 03/22/2019 - 08:45 |
World Water Day - Making every drop count |
|
Mon, 03/18/2019 - 06:37 |
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD |
|
Thu, 03/07/2019 - 07:14 |
Novel antibody shows potential to transform treatment of rare form of psoriasis |
|
Fri, 03/01/2019 - 06:35 |
New Chief Medical Officer appointed |
|
Thu, 02/28/2019 - 09:15 |
Boehringer Ingelheim launches Frontline Flagship Store on Tmall |
|
Tue, 02/26/2019 - 08:46 |
Boehringer Ingelheim and GNA Biosolutions partner on emergency veterinary diagnostics development |
|
Mon, 02/11/2019 - 09:02 |
Boehringer Ingelheim reaffirms its leading position in hatchery vaccination with its vector vaccines at IPPE 2019 |
|
Thu, 01/24/2019 - 12:57 |
Boehringer Ingelheim launches first veterinary vaccines produced in China |
|
Thu, 01/17/2019 - 11:18 |
Boehringer Ingelheim Biopharmaceuticals China expands commercial manufacturing capacities |
|
Thu, 01/03/2019 - 06:29 |
Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies |
|
Tue, 12/18/2018 - 05:33 |
Boehringer Ingelheim and the Muskan Foundation inaugurate facility for children with multiple disabilities |
|
Mon, 12/17/2018 - 03:05 |
Boehringer Ingelheim launches a tool to aid in the prevention of African swine fever |
|
Thu, 12/13/2018 - 17:27 |
Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK HVT + IBD since 2006 |
|
Thu, 12/13/2018 - 07:03 |
Boehringer Ingelheim vaccinates over 100 billion birds with VAXXITEK HVT + IBD since 2006 |
|
Tue, 12/11/2018 - 05:36 |
Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market |
|
Mon, 12/03/2018 - 22:47 |
Boehringer Ingelheim launches LastMile initiative to address major barriers in animal healthcare sector in Sub-Saharan Africa |
|
Wed, 11/28/2018 - 01:29 |
Boehringer Ingelheim announces two new claims for Nexgard and Nexgard Spectra in the EU and Australia |
|
Thu, 11/22/2018 - 05:14 |
Boehringer Ingelheim partners with Ipsos to gain insights on human-animal bond in Europe |
|
Wed, 11/14/2018 - 20:47 |
Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies |
|
Tue, 11/06/2018 - 23:07 |
Boehringer Ingelheim becomes an official partner to CatCare for Life |
|
Wed, 10/31/2018 - 12:28 |
Boehringer Ingelheim achieves next expansion milestone in biologics production in the US |
|
Thu, 10/25/2018 - 12:26 |
Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals |
|
Tue, 10/23/2018 - 12:53 |
Boehringer Ingelheim announces the winners of 2018 BVDzero Case Awards |
|
Fri, 10/19/2018 - 11:02 |
Real-world study shows using Giotrif |
|
Fri, 10/12/2018 - 00:16 |
Boehringer Ingelheim increases awareness of health with the micro enterprise project Elephants in South India |
|
Thu, 10/11/2018 - 23:49 |
Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in Lyon, France |
|
Sun, 09/30/2018 - 23:13 |
2018 Animal Welfare Medals: Boehringer Ingelheim recognizes outstanding research in animal health |
|
Thu, 09/27/2018 - 23:18 |
Boehringer Ingelheim is committed to joining forces in the global fight against rabies |
|
Thu, 09/27/2018 - 02:09 |
New vaccine against Bovine Respiratory Disease: Boehringer Ingelheim reaffirms its focus on prevention |
|
Wed, 09/26/2018 - 01:47 |
Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC |
|
Mon, 09/24/2018 - 23:59 |
Results of LUME-Meso trial in malignant pleural mesothelioma presented at the 19 th World Conference on Lung Cancer (WCLC 2018) |
|
Thu, 09/13/2018 - 14:58 |
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies |
|
Mon, 09/10/2018 - 10:19 |
Changes to the Leadership of Boehringer Ingelheims Corporate Department Medicine |
|
Tue, 09/04/2018 - 23:21 |
Boehringer Ingelheim launches the first liquid solution for hypertension in cats |
|
Mon, 09/03/2018 - 23:17 |
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases |
|
Mon, 09/03/2018 - 15:37 |
Boehringer Ingelheim Biopharmaceuticals China supports BeiGene in its China NDA submission of anti-PD-1 antibody, tislelizumab |
|
Tue, 08/21/2018 - 16:55 |
New tablet production facility in Ingelheim: Centerpiece for global launches |
|
Mon, 08/20/2018 - 18:32 |
Development partner Boehringer Ingelheim supplies clinical material manufactured in China for new cancer drug |
|
Thu, 08/02/2018 - 16:48 |
Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa |
|
Wed, 08/01/2018 - 16:08 |
Boehringer Ingelheim achieves modest growth in the first half of 2018 |
|
Tue, 07/10/2018 - 05:44 |
Boehringer Ingelheim invests more than 200 million to establish strategic production center for Veterinary Public Health in France |
